论文部分内容阅读
四分之三的哮喘患者在夜间往往会因咳嗽、喘息和气促而惊醒.这种夜间哮喘伴有明显的睡眠障碍和夜醒次数增加.并通常成为病人的主诉症状.迄今对改善夜间哮喘患者的睡眠质量仍无治疗方法.沙美特罗(salmeterol)是一种新型吸入用的β兴奋剂,吸入一次可使支气管舒张作用持续12小时.本文的研究旨在评价夜喘患者吸入沙美特罗对夜间支气管痉挛和睡眠质量的作用.病人和方法 20例夜间哮喘患者,女13例,男7例,平均年龄39(18～60)岁,用随机、双盲、交叉研究,比较下列三种气雾剂的吸入治疗:沙美特
Three-quarters of patients with asthma often wake up during the night due to cough, wheezing, and shortness of breath.This nighttime asthma with significant sleep disturbances and increased number of night wakes is often the chief complaint of the patient.To date, patients with nocturnal asthma Of the sleep quality is still no treatment salmeterol is a new type of inhaled beta agonist, inhaled bronchodilator effect can be sustained for 12 hours.The purpose of this paper is to evaluate the evaluation of patients with nocturnal asthma inhalation of salmeterol Nocturnal bronchospasm and sleep quality.Patients and methods 20 cases of nighttime asthma patients, 13 females, 7 males, average age 39 (18 ~ 60) years, with a randomized, double-blind, crossover study, the following three kinds of gas Aerosol inhalation treatment: Salmeterol